Position in AZN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$121,736
New position
Shares Held
642
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,227
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investors Research Corp holds $5,482,615 across 10 Drug Manufacturers - General names. AZN ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
8,779 | $1,128,101 | |
| 2 | PFE |
Pfizer Inc
|
38,962 | $938,204 | |
| 3 | NVO |
Novo Nordisk A S
|
18,225 | $873,706 | |
| 4 | GSK |
GSK plc
|
14,952 | $783,783 | |
| 5 | SNY |
Sanofi
|
16,468 | $702,524 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,628 | $497,145 | |
| 7 | BIIB |
Biogen Inc.
|
1,641 | $354,554 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
642 | $121,736 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,736 | 642 | Shares | Sole | 2026-07-10 | |
| No filing history on record for this holder in this stock. | ||||||